Gregory Cadelina

2.1k total citations
18 papers, 1.3k citations indexed

About

Gregory Cadelina is a scholar working on Hepatology, Physiology and Epidemiology. According to data from OpenAlex, Gregory Cadelina has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Gregory Cadelina's work include Liver Disease and Transplantation (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Gregory Cadelina is often cited by papers focused on Liver Disease and Transplantation (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Gregory Cadelina collaborates with scholars based in United States and Mexico. Gregory Cadelina's co-authors include Roberto J. Groszmann, William C. Sessa, Sheldon Milstien, Yasuko Iwakiri, Guadalupe García–Tsao, Sriparna Das, Roland Wiest, Mauricio R. Loureiro‐Silva, Vijay H. Shah and Andreas Papapetropoulos and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.

In The Last Decade

Gregory Cadelina

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Cadelina United States 15 783 542 368 319 273 18 1.3k
Kenji Mizuno Japan 16 134 0.2× 139 0.3× 248 0.7× 110 0.3× 302 1.1× 82 867
Araní Casillas-Ramírez Spain 18 507 0.6× 380 0.7× 636 1.7× 100 0.3× 245 0.9× 39 999
Teruo Jojima Japan 18 105 0.1× 539 1.0× 412 1.1× 167 0.5× 355 1.3× 47 1.3k
Juan Gimenez United States 6 108 0.1× 139 0.3× 214 0.6× 85 0.3× 198 0.7× 16 986
Narjes Nasiri‐Ansari Greece 14 85 0.1× 456 0.8× 230 0.6× 129 0.4× 303 1.1× 36 1.0k
Taro Wasada Japan 17 98 0.1× 486 0.9× 226 0.6× 168 0.5× 336 1.2× 54 1.2k
Hiroki Sugita Japan 19 39 0.0× 268 0.5× 392 1.1× 343 1.1× 387 1.4× 44 1.2k
Luis Álvarez Spain 16 141 0.2× 201 0.4× 320 0.9× 53 0.2× 211 0.8× 28 956
George G. Schweitzer United States 19 87 0.1× 577 1.1× 278 0.8× 567 1.8× 624 2.3× 33 1.4k
Francesco Massimo Perla Italy 13 82 0.1× 407 0.8× 69 0.2× 150 0.5× 128 0.5× 23 807

Countries citing papers authored by Gregory Cadelina

Since Specialization
Citations

This map shows the geographic impact of Gregory Cadelina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cadelina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cadelina more than expected).

Fields of papers citing papers by Gregory Cadelina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Cadelina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cadelina. The network helps show where Gregory Cadelina may publish in the future.

Co-authorship network of co-authors of Gregory Cadelina

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Cadelina. A scholar is included among the top collaborators of Gregory Cadelina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Cadelina. Gregory Cadelina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Snyder, Lawrence B., John J. Flanagan, Yimin Qian, et al.. (2021). Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer. Cancer Research. 81(13_Supplement). 44–44. 74 indexed citations
2.
Qian, Yimin, Monica Andreoli, Mark Bookbinder, et al.. (2019). Abstract P5-04-18: ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer. Cancer Research. 79(4_Supplement). P5–4. 106 indexed citations
3.
Cacace, Angela, John J. Flanagan, Michael Berlin, et al.. (2019). O5‐04‐05: A NEW THERAPEUTIC STRATEGY FOR TAUOPATHIES: DISCOVERY OF HIGHLY POTENT BRAIN PENETRANT PROTACTM DEGRADER MOLECULES THAT TARGET PATHOLOGIC TAU PROTEIN SPECIES. Alzheimer s & Dementia. 15(7S_Part_31). 2 indexed citations
4.
Barten, Donna M., Gregory Cadelina, & Michael R. Weed. (2017). Dosing, collection, and quality control issues in cerebrospinal fluid research using animal models. Handbook of clinical neurology. 146. 47–64. 13 indexed citations
5.
6.
Barten, Donna M., Gregory Cadelina, Nina Hoque, et al.. (2011). Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers. Journal of Alzheimer s Disease. 24(s2). 127–141. 69 indexed citations
7.
DePasquale, Michael, Gregory Cadelina, Delvin R. Knight, et al.. (2009). Mechanistic studies of blood pressure in rats treated with a series of cholesteryl ester transfer protein inhibitors. Drug Development Research. 70(1). 35–48. 21 indexed citations
8.
Wiest, Reiner, et al.. (2003). Bacterial Translocation Up–Regulates Gtp–Cyclohydrolase I in Mesenteric Vasculature of Cirrhotic Rats. Hepatology. 38(6). 1508–1515. 73 indexed citations
9.
Tsai, Ming‐Hung, Yasuko Iwakiri, Gregory Cadelina, William C. Sessa, & Roberto J. Groszmann. (2003). Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology. 125(5). 1452–1461. 56 indexed citations
10.
Loureiro‐Silva, Mauricio R., Gregory Cadelina, Yasuko Iwakiri, & Roberto J. Groszmann. (2003). A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. Journal of Hepatology. 39(6). 940–946. 54 indexed citations
11.
Loureiro‐Silva, Mauricio R., Gregory Cadelina, & Roberto J. Groszmann. (2003). Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(4). G567–G574. 46 indexed citations
12.
Loureiro‐Silva, Mauricio R., et al.. (2002). Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers. Hepatology. 36(2). 381–385. 39 indexed citations
13.
Iwakiri, Yasuko, Gregory Cadelina, William C. Sessa, & Roberto J. Groszmann. (2002). Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. American Journal of Physiology-Gastrointestinal and Liver Physiology. 283(5). G1074–G1081. 67 indexed citations
14.
Loureiro‐Silva, Mauricio R., Gregory Cadelina, & Roberto J. Groszmann. (2001). Nitric oxide modulates both pre-sinusoidal and sinusoidal responses to phenylephrine in normal rat liver. Gastroenterology. 120(5). A9–A9. 3 indexed citations
15.
Shah, Vijay H., Murat Törüner, Gregory Cadelina, et al.. (1999). Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology. 117(5). 1222–1228. 256 indexed citations
16.
Wiest, Roland, Sriparna Das, Gregory Cadelina, et al.. (1999). Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. Journal of Clinical Investigation. 104(9). 1223–1233. 236 indexed citations
17.
Angulo, Paul, et al.. (1998). The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology. 28(1). 17–21. 23 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Mizuno Breakdown of academic impact, for papers by Araní Casillas-Ramírez Breakdown of academic impact, for papers by Teruo Jojima Breakdown of academic impact, for papers by Juan Gimenez Breakdown of academic impact, for papers by Narjes Nasiri‐Ansari Breakdown of academic impact, for papers by Taro Wasada Breakdown of academic impact, for papers by Hiroki Sugita Breakdown of academic impact, for papers by Luis Álvarez Breakdown of academic impact, for papers by George G. Schweitzer Breakdown of academic impact, for papers by Francesco Massimo Perla
Rankless by CCL
2026